Berenberg Bank Reaffirms Buy Rating for Informa (LON:INF)

Informa (LON:INF – Get Free Report)‘s stock had its “buy” rating reiterated by Berenberg Bank in a note issued to investors on Thursday, MarketBeat.com reports. They currently have a GBX 1,040 price target on the stock. Berenberg Bank’s price target indicates a potential upside of 16.12% from the stock’s previous close.

Other research analysts have also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,140 price target on shares of Informa in a report on Friday, July 31st. JPMorgan Chase & Co. decreased their target price on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research note on Thursday, July 2nd. Finally, Citigroup raised their price objective on Informa from GBX 990 to GBX 1,090 and gave the stock a “buy” rating in a research report on Wednesday, August 12th. Six equities research analysts have rated the stock with a Buy rating. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of GBX 1,160.

Get Informa alerts:

Read Our Latest Research Report on INF

Informa Stock Performance

INF opened at GBX 895.60 on Thursday. Informa has a twelve month low of GBX 719 and a twelve month high of GBX 1,000. The business’s 50 day moving average is GBX 893.22 and its 200-day moving average is GBX 853.04. The company has a current ratio of 0.55, a quick ratio of 1.70 and a debt-to-equity ratio of 64.99. The stock has a market cap of £11.19 billion, a PE ratio of 52.37, a price-to-earnings-growth ratio of 0.75 and a beta of 0.71.

Informa (LON:INF – Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported GBX 26.70 earnings per share (EPS) for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. On average, analysts predict that Informa will post 59.32 earnings per share for the current year.

Informa Company Profile

(Get Free Report)

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.

See Also

• Five stocks we like better than Informa
• Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
• Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
• Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
• Arista Networks Plugs Into All-Time Highs

Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.